Prophylactic Measures During Induction for Acute Myeloid Leukemia.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 3, p. 1, doi. 10.1007/s11912-017-0574-9
- By:
- Publication type:
- Article
Works matching IS 15233790 AND DT 2017 AND VI 19 AND IP 3
Results: 8
1
2
Treatment of Acute Myeloid Leukemia with the FLT3 Gene Mutation.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 3, p. 1, doi. 10.1007/s11912-017-0573-x
- By:
- Publication type:
- Article
3
Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 3, p. 1, doi. 10.1007/s11912-017-0578-5
- By:
- Publication type:
- Article
4
The Role of Surgery for Melanoma in an Era of Effective Systemic Therapy.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 3, p. 1, doi. 10.1007/s11912-017-0575-8
- By:
- Publication type:
- Article
5
Extended Endocrine Therapy: Is 5 Years Enough?
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 3, p. 1, doi. 10.1007/s11912-017-0576-7
- By:
- Publication type:
- Article
6
Bone Modifier Use as Adjuvant Therapy for Early Breast Cancer.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 3, p. 1, doi. 10.1007/s11912-017-0577-6
- By:
- Publication type:
- Article
7
Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 3, p. 1, doi. 10.1007/s11912-017-0579-4
- By:
- Publication type:
- Article
8
Erratum to: Update on Management of Cancer-Related Cachexia.
- Published in:
- 2017
- By:
- Publication type:
- Erratum